Accepted for/Published in: Journal of Medical Internet Research
Date Submitted:
Open Peer Review Period: -
Date Accepted:
Date Submitted to PubMed:
- Xiaopeng W, Jiaxin Z, Chang L, Haowen Z, Guanduo S, Jingming Z, Haijun Y, Haijun Y
- Deciphering Lactate Metabolism in Colorectal Cancer: Prognostic Modeling, Immune Infiltration, and Gene Mutation Insights
- Journal of Medical Internet Research
- DOI: 10.2196/11848
- PMID: 30303485
- PMCID: 6352016
Deciphering Lactate Metabolism in Colorectal Cancer: Prognostic Modeling, Immune Infiltration, and Gene Mutation Insights
Abstract
This study offers an in-depth analysis of the role of lactate metabolism in colorectal cancer (CRC), highlighting its significance in the tumor microenvironment (TME) and therapeutic response. Utilizing single-cell and transcriptomic data from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA), we identified key lactate metabolic activities, particularly in the monocyte/macrophage subpopulation. Seven lactate metabolism-associated genes were significantly linked to CRC prognosis and used to construct a predictive model. This model accurately forecasts patient outcomes and reveals notable differences in immune infiltration and gene mutation profiles between high- and low-risk groups. High-risk patients demonstrated elevated immune cell infiltration, increased mutation frequencies, and heightened sensitivity to specific drugs (AZD6482, tozasertib, and SB216763), providing a foundation for personalized treatment approaches. Additionally, a nomogram integrating clinical and metabolic data effectively predicted 1-, 3-, and 5-year survival rates. These findings underscore the pivotal role of lactate metabolism in CRC prognosis and suggest novel avenues for therapeutic intervention.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it’s website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.